Literature DB >> 1787645

A glomerular permeability factor produced by human T cell hybridomas.

A Koyama1, M Fujisaki, M Kobayashi, M Igarashi, M Narita.   

Abstract

A glomerular permeability factor produced by human T cell hybridomas. T cell hybridomas derived from the T cells of a patient with mammal change nephrotic syndrome (MCNS) made a glomerular permeability factor (GPF). Sufficient quantities of GPF were available for further analysis and characterization. We obtained four stable clones of human T cell hybridomas which produced a glomerular permeability factor. When this factor was injected intravenously into rats, significant proteinurias were induced, and in normal human lymphocyte culture, GPF enhanced Concanavalin-A (Con-A) induced lymphocyte blastogenesis by greater than ten fold. GPF was cytotoxic to tumor cell lines of epithelial origin, but only cytostatic to tumor cells of hematopoietic origin. Electron microscopy studies, with polyethyleneimine (PEI) staining, indicated that GPF induced the changes in the arrangement of PEI particles and partial fusion of glomerular epithelial cells in the rats given this factor intravenously. The molecular weight of GPF were estimated to be between 60,000 and 160,000 daltons. The molecular weight of the factor and its TNF like activity, we speculated that the factor was a lymphokine, like lymphotoxins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1787645     DOI: 10.1038/ki.1991.232

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  72 in total

Review 1.  The renaissance of corticotropin therapy in proteinuric nephropathies.

Authors:  Rujun Gong
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

2.  Proteinuria: is it all in the foot?

Authors:  Pierre Ronco
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient.

Authors:  Benjamin D Humphreys; Vijay K Vanguri; Joel Henderson; Joseph H Antin
Journal:  Nat Clin Pract Nephrol       Date:  2006-09

Review 4.  Role of T cells and dendritic cells in glomerular immunopathology.

Authors:  Christian Kurts; Felix Heymann; Veronika Lukacs-Kornek; Peter Boor; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

5.  T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.

Authors:  Carlos Araya; Leila Diaz; Clive Wasserfall; Mark Atkinson; Wei Mu; Richard Johnson; Eduardo Garin
Journal:  Pediatr Nephrol       Date:  2009-06-03       Impact factor: 3.714

6.  Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.

Authors:  Mai Sato; Koichi Kamei; Masao Ogura; Kenji Ishikura; Shuichi Ito
Journal:  Clin Exp Nephrol       Date:  2017-04-22       Impact factor: 2.801

7.  Low birth weight, but not postnatal weight gain, aggravates the course of nephrotic syndrome.

Authors:  Christian Plank; Iris Ostreicher; Katalin Dittrich; Rüdiger Waldherr; Manfred Voigt; Kerstin Amann; Wolfgang Rascher; Jörg Dötsch
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

8.  Early use of plasmapheresis for recurrent post-transplant FSGS.

Authors:  Madhura Pradhan; Julie Petro; Joanne Palmer; Kevin Meyers; H Jorge Baluarte
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

Review 9.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

Review 10.  Mediation of immune glomerular injury.

Authors:  W G Couser
Journal:  Clin Investig       Date:  1993-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.